期刊文献+

相对定量分析异烟肼、链霉素单耐药与多耐药结核分枝杆菌临床分离株的蛋白质组差异 被引量:2

Quantitative proteomics analysis of isoniazid,streptomycin mono-drug resistant and poly-drug resistant clinical isolates of Mycobacterium tuberculosis
原文传递
导出
摘要 【目的】探讨异烟肼(isoniazid,INH)、链霉素(streptomycin,SM)单耐药结核分枝杆菌(Mycobacterium tuberculosis,MTB)与INH/SM多耐药MTB蛋白质组差异。【方法】应用i TRAQ结合Nano LC-MS/MS定量蛋白质组学技术,分析临床分离INH、SM或INH/SM耐药MTB与H37Rv标准株间均表达差异蛋白;并以INH/SM耐药MTB与H37Rv比值为对照,相对定量分析单耐药与多耐药MTB蛋白表达差异倍数;运用DAVID 6.7分析差异蛋白生物功能;STITCH 5.0分析差异蛋白与INH和SM相互作用。【结果】与H37Rv标准株比较,58个蛋白在INH、SM耐药与INH/SM耐药MTB间均有表达差异,共同差异蛋白生物功能主要为氧化还原酶活性和转移酶活性;主要参与丙酸代谢信号通路。共同差异蛋白中,与INH/SM耐药MTB比较,Rv2986c和Rv1908c在INH、SM耐药MTB均表达上调>1.25倍;Rv3133c和Rv0577则均表达下调<0.7倍;生物信息学预测发现以上4种蛋白可直接或间接与INH、SM进行相互作用。【结论】INH、SM单耐药和INH/SM多耐药MTB蛋白表达谱有较大差异,蛋白Rv2986c、Rv1908c、Rv3133c和Rv0577表达水平及相互作用可能与INH和SM耐药有关。 [Objective] To investigate the differentially expressed proteins between isoniazid,streptomycin monoand poly-drug resistant clinical isolate strains of Mycobacterium tuberculosis.[Methods] Cellular proteins were extracted from isoniazid,streptomycin mono-and poly-drug resistant clinical isolates M.tuberculosis and H37 Rv.Differentially expressed proteins were identified through isobaric tags for relative and absolute quantification(i TRAQ) combined with Nano LC-MS/MS technology.The biological function and interaction among differentially expressed proteins and isoniazid or streptomycin were analyzed by DAVID 6.7 and STITCH 5.0,respectively.[Results] 58 differentially expressed proteins were identified in isoniazid,streptomycin mono-drug resistant strains and isoniazid,streptomycin poly-drug resistance strain compared with the proteomic profiles of H37 Rv.The biological function of differentially expressed proteins mainly relates to oxidoreductase and transferase activity.Compared with isoniazid and streptomycin poly-drug resistance strain,two proteins(Rv2986 c and Rv1908 c) were up-regulated over 1.25 folds and two proteins(Rv3133 c and Rv0577) were down-regulated less than 0.7 fold in isoniazid,streptomycin mono-drug resistant strains.Bioinformatics predicted that the four proteins interact with isoniazid and streptomycin directly or indirectly.[Conclusion] The expressed level or the interactions together of Rv2986 c,Rv1908 c,Rv3133 c and Rv0577 is likely to be related to isoniazid and streptomycin resistance in M.tuberculosis.
作者 朱传智 赵雁林 黄香玉 逄宇 庄玉辉 何秀云 Chuanzhi Zhu;Yanlin Zhao;Xiangyu Huang;Yu Pang;Yuhui Zhuang;Xiuyun He(Beijing Key Laboratory of Transplantation and Immune Regulation, The 309th Hospital of PLA, Beijing 100091, China;National Tuberculosis Reference Laboratory, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China;Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Laboratory of Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China)
出处 《微生物学报》 CAS CSCD 北大核心 2018年第7期1182-1190,共9页 Acta Microbiologica Sinica
基金 国家重大传染病专项(2008ZX10003-009)
关键词 结核分枝杆菌 异烟肼 链霉素 定量蛋白质组 Mycobacterium tuberculosis isoniazid streptomycin quantitative proteomics
  • 相关文献

参考文献3

二级参考文献23

  • 1范玉美,肖和平,梅建.上海市首次复治肺结核患者的耐药性分析[J].中华结核和呼吸杂志,2006,29(10):698-701. 被引量:27
  • 2吴小林.治疗结核病新药和药物作用靶位[J].国外医药(抗生素分册),2007,28(2):70-73. 被引量:5
  • 3World Health Organization, Global tuberculosis report 2013. World Health Organization, 2013.
  • 4Tufariello J M, Chan J, Flynn J L. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis, 2003, 3: 578-590.
  • 5Gengenbacher M, Kaufmann S H. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev, 2012, 36: 514-532.
  • 6Gupta A, Kaul A, Tsolaki A G, et al. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology, 2012, 217: 363-374.
  • 7Walburger A, Koul A, Ferrari G, et al. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science, 2004, 304: 1800-1804.
  • 8Cole S T, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393: 537-544.
  • 9Thompson J D, Higgins D G, Gibson T J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res, 1994, 22: p. 4673-4680.
  • 10Koul A, Choidas A, Tyagi A K, et al. Serine/threonine protein kinases PknF and PknG of Mycobacterium tuberculosis: characterization and localization. Microbiology, 2001, 147: 2307-2314.

共引文献17

同被引文献6

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部